Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adults With Chronic HCV Infection Who Have Previously Received Treatment With Direct-Acting Antiviral Therapy

Long Beach

Los Angeles

Palo Alto

Pasadena

Rialto

San Diego

San Francisco

Aurora

Englewood

Washington D.C.

Gainesville

Miami

Orlando

Wellington

Atlanta

Marietta

Chicago

Indianapolis

Baltimore

Catonsville

Boston

Ann Arbor

Detroit

Kansas City

St Louis

Hillsborough

New York

The Bronx

Asheville

Philadelphia

Pittsburgh

Providence

Germantown

Knoxville

Nashville

Houston

San Antonio

Murray

Falls Church

Norfolk

Richmond

Seattle

Madison

Camperdown

Darlinghurst

Herston

Clayton

Fitzroy

Melbourne

Calgary

Edmonton

Vancouver

Brampton

Toronto

Montreal

Clermont-Ferrand

Clichy

Créteil

Grenoble

Lille

Limoges

Lyon

Marseille

Montpellier

Nice

Paris

Pessac

Rennes

Rouen

Strasbourg

Toulouse

Vandœuvre-lès-Nancy

Villejuif

Berlin

Bonn

Cologne

Frankfurt am Main

Hamburg

Hanover

Christchurch

Grafton

San Juan

London

Manchester

Nottingham

Portsmouth